Anixa Biosciences (ANIX)'s 30-day implied volatility (IV30) was 65.7% at the close on November 13, 2026, down from 77.3% the day before, against a 52-week range of 42.6% to 160.3%. Its 20-day historical volatility was 81.8%.
Data as of November 13, 2026.